Clinical Trial Update: CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating CERebrolysine and its effect on the blood-brain barrier in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• CERebrolysine

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Acute Ischemic Stroke | Phase 4 | Status: UNKNOWN